Xencor | XNCR - PE Price to Earnings


Xencor reported 29.92 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen 25.31 15.82 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Biogen 14.02 4.63 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
J&J 23.62 0.86 Dec/2025
Merck 13.92 5.08 Dec/2025
Novartis 17.85 2.11 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Xencor 29.92 3.22 Sep/2022